# KALA BIO, Inc.: filings

KALA · Nasdaq · CIK 1479419 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kala.md) · [Financials](/companies/kala/financials.md) · [Filings](/companies/kala/filings.md) · [Insiders](/companies/kala/insiders.md)

## Reports and events: 198 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 242, 8-K 122, 3 40, 10-Q 28, 144 24, SC 13G/A 15, SC 13G 13, CORRESP 12, D 12, DEFA14A 12, DEF 14A 11, S-8 11, UPLOAD 11, SC 13D/A 10, 10-K 9, 424B5 9, EFFECT 9, S-3 8, SC 13D 7, SCHEDULE 13G 7, SCHEDULE 13G/A 7, CT ORDER 6, SCHEDULE 13D/A 5, 424B3 4, 4/A 4, DRS/A 4, PRE 14A 4, 8-K/A 3, S-3/A 3, 3/A 2, 424B2 2, ARS 2, DRSLTR 2, NT 10-Q 2, SC TO-I/A 2, 424B4 1, 8-A12B 1, 8-A12G 1, DRS 1, NT 10-K 1, PRER14A 1, S-1 1, S-1/A 1, SCHEDULE 13D 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-24 | 20:10 ET | [DEF 14A](/filings/0001829126-26-010384.md) | Proxy statement, period 2026-11-03 | 0001829126-26-010384 |
| 2026-09-10 | 21:24 ET | [8-K](/filings/0001829126-26-009999.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001829126-26-009999 |
| 2026-09-09 | 21:06 ET | [8-K](/filings/0001829126-26-009946.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001829126-26-009946 |
| 2026-08-28 | 10:45 ET | [8-K](/filings/0001829126-26-009454.md) | 3.01 Delisting notice | 0001829126-26-009454 |
| 2026-08-19 | 20:16 ET | [10-Q](/filings/0001104659-26-098783.md) | Quarterly report, period 2026-06-30 | 0001104659-26-098783 |
| 2026-07-23 | 00:13 ET | [8-K](/filings/0001829126-26-007760.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001829126-26-007760 |
| 2026-07-02 | 21:37 ET | [SCHEDULE 13D/A](/filings/0001829126-26-007224.md) | Ownership report, active investor, amended | 0001829126-26-007224 |
| 2026-05-15 | 19:30 ET | [10-Q](/filings/0001104659-26-062397.md) | Quarterly report, period 2026-03-31 | 0001104659-26-062397 |
| 2026-05-07 | 20:07 ET | [8-K](/filings/0001829126-26-004744.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001829126-26-004744 |
| 2026-04-15 | 20:03 ET | [10-K](/filings/0001104659-26-043782.md) | Annual report, period 2025-12-31 | 0001104659-26-043782 |
| 2026-03-04 | 14:16 ET | [8-K](/filings/0001829126-26-001911.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure | 0001829126-26-001911 |
| 2026-02-20 | 21:05 ET | [8-K](/filings/0001829126-26-001534.md) | 5.02 Departure or appointment of officers or directors | 0001829126-26-001534 |
| 2026-02-06 | 21:14 ET | [SCHEDULE 13D](/filings/0001829126-26-001059.md) | Ownership report, active investor | 0001829126-26-001059 |
| 2026-02-05 | 21:05 ET | [8-K](/filings/0001829126-26-000995.md) | 5.02 Departure or appointment of officers or directors | 0001829126-26-000995 |
| 2026-02-02 | 11:01 ET | [8-K](/filings/0001829126-26-000837.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001829126-26-000837 |
| 2026-01-23 | 21:05 ET | [8-K](/filings/0001829126-26-000502.md) | 3.01 Delisting notice | 0001829126-26-000502 |
| 2026-01-08 | 21:07 ET | [8-K](/filings/0001829126-26-000110.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001829126-26-000110 |
| 2026-01-06 | 12:30 ET | [8-K](/filings/0001829126-26-000055.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-000055 |
| 2026-01-02 | 21:15 ET | [8-K](/filings/0001829126-26-000023.md) | 8.01 Other events | 0001829126-26-000023 |
| 2025-12-30 | 21:12 ET | [DEF 14A](/filings/0001829126-25-010356.md) | Proxy statement, period 2026-01-30 | 0001829126-25-010356 |
| 2025-12-29 | 21:52 ET | [8-K](/filings/0001829126-25-010330.md) | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors | 0001829126-25-010330 |
| 2025-12-16 | 18:28 ET | [8-K](/filings/0001829126-25-010045.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001829126-25-010045 |
| 2025-12-16 | 14:32 ET | [8-K](/filings/0001829126-25-010037.md) | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001829126-25-010037 |
| 2025-12-05 | 21:05 ET | [8-K](/filings/0001829126-25-009747.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001829126-25-009747 |
| 2025-11-25 | 21:15 ET | [8-K](/filings/0001829126-25-009432.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001829126-25-009432 |
| 2025-11-19 | 12:26 ET | [10-Q](/filings/0001104659-25-113927.md) | Quarterly report, period 2025-09-30 | 0001104659-25-113927 |
| 2025-11-12 | 21:01 ET | [8-K](/filings/0001104659-25-110316.md) | 3.01 Delisting notice | 0001104659-25-110316 |
| 2025-11-10 | 13:00 ET | [8-K](/filings/0001104659-25-108844.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events | 0001104659-25-108844 |
| 2025-10-20 | 12:00 ET | [8-K](/filings/0001104659-25-100620.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-25-100620 |
| 2025-10-15 | 22:24 ET | [SCHEDULE 13D/A](/filings/0001193125-25-240483.md) | Ownership report, active investor, amended | 0001193125-25-240483 |
| 2025-10-02 | 00:37 ET | [SCHEDULE 13D/A](/filings/0001104659-25-096281.md) | Ownership report, active investor, amended | 0001104659-25-096281 |
| 2025-10-02 | 20:15 ET | [8-K/A](/filings/0001104659-25-096071.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-096071 |
| 2025-10-01 | 23:31 ET | [SCHEDULE 13D/A](/filings/0001193125-25-227218.md) | Ownership report, active investor, amended | 0001193125-25-227218 |
| 2025-10-01 | 12:00 ET | [8-K](/filings/0001104659-25-095342.md) | 2.04 Item not in the standard list | 0001104659-25-095342 |
| 2025-09-29 | 12:08 ET | [8-K](/filings/0001104659-25-094125.md) | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-094125 |
| 2025-09-18 | 20:24 ET | [8-K](/filings/0001104659-25-091272.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001104659-25-091272 |
| 2025-09-02 | 12:08 ET | [8-K](/filings/0001104659-25-086011.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-086011 |
| 2025-08-08 | 12:06 ET | [10-Q](/filings/0001558370-25-010853.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010853 |
| 2025-08-08 | 12:01 ET | [8-K](/filings/0001558370-25-010850.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010850 |
| 2025-07-09 | 12:08 ET | [8-K](/filings/0001104659-25-066593.md) | 8.01 Other events | 0001104659-25-066593 |
| 2025-05-14 | 20:22 ET | [10-Q](/filings/0001558370-25-007763.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007763 |
| 2025-05-14 | 12:01 ET | [8-K](/filings/0001558370-25-007664.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007664 |
| 2025-04-11 | 20:09 ET | [8-K](/filings/0001104659-25-034210.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-034210 |
| 2025-03-31 | 12:03 ET | [10-K](/filings/0001558370-25-004081.md) | Annual report, period 2024-12-31 | 0001558370-25-004081 |
| 2025-03-31 | 12:01 ET | [8-K](/filings/0001558370-25-004080.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-004080 |
| 2025-02-12 | 13:06 ET | [8-K](/filings/0001104659-25-011852.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-011852 |
| 2024-12-31 | 21:18 ET | [SCHEDULE 13D/A](/filings/0001104659-24-132857.md) | Ownership report, active investor, amended | 0001104659-24-132857 |
| 2024-12-30 | 14:10 ET | [8-K](/filings/0001104659-24-132308.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-132308 |
| 2024-11-12 | 21:01 ET | [10-Q](/filings/0001558370-24-015302.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015302 |
| 2024-11-12 | 13:07 ET | [8-K](/filings/0001558370-24-015168.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015168 |

Page 1 of 4. [Older](/companies/kala/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.